Module 14 - Reproduction Flashcards
Proposed uses of uterotonics
To empty Uterus- labor/ terminate pregnancy
Stop Bleeding- Immediately Postpartum/ late postpartum hemorrhage
Subinvolution- reduction of uterus to its normal size after childbirth
Potential benefits of Oral contraceptives
Avoid unwanted pregnancy Decrease menorrhagia Decrease dysmenorrhea Decrease ectopic pregnancy Decreased iron deficiency anemia Decreased PID Decrease risk of ovarian and endometrial cancer
Potential Harm of Oral Contraceptives
Increase risk of MI/stroke/ VTE
Relative CI if woman > 35 yrs and smokes due to increased risk of VTE and cardiovascular events*
slight increased risk of breast cancer (if at all)
AE recommended formulation: Acne
higher Estrogen dose, lower androgen potency
AE recommended formulation: breakthrough bleeding
higher Estrogen and progestin potency
lower androgen potency
AE recommended formulation: absent/ light menstrual flow
higher estrogen, lower progestin dose
AE recommended formulation: Depression
lower progestin potency
AE recommended formulation: Moodiness or irritability
lower Progestin potency
AE recommended formulation: HA (not menstrual migraines)
lower estrogen and progestin potency
AE recommended formulation: breast soreness
lower estrogen and progestin potency
AE recommended formulation: weight gain
lower estrogen and progestin potency
AE recommended formulation: severe menstrual cramps
higher progestin potency
AE recommended formulation: endometriosis or endometriosis prevention
lower estrogen, higher progestin and androgen potency
AE recommended formulation: endometriosis or endometriosis prevention
lower estrogen, higher progestin and androgen potency
5a reductase inhibitor
competitive inhibitor
More specific for type II receptors in scalp
Inhibits conversion of testosterone to DHT
Finasteride
Med used to treat BPH and alopecia
Finasteride
5a reductase inhibitor
competitive inhibitor
Inhibits conversion of testosterone to DHT
Dutasteride
Aromatase inhibitor
competitive inhibitor
Inhibits conversion of androgen to estrogen
Anastrazole, Letrozole
Aromatase Inhibitor
Noncompetitive Inhibitor*
Inhibits conversion of androgen to estrogen
Exemestane, Formestane
SERM, Can stimulate endometrial cancer- pro-estrogenic effect on endometrium, antagonistic estrogenic effects on breast tissue
Tamoxifen
SERM, Inhibits growth of estrogen dependent (ER+) breast tumors, agonist activity in bones can delay or prevent osteoporosis, does not stimulate endometrium
Raloxifene (Evista)
SERM, ER antagonist in hypothalamus gland anterior pituitary gland = increased GnRH , Induces ovulation via partial agonism in ovaries
Clomiphene (clomid)